Regenxbio's chart data is dated 2026-10-09. Recorded technical signals: Golden cross. There are 4 published signal records.
Regenxbio last closed at $8.07 (-0.25%) on 2026-10-09. Signals today: Golden cross. Listed on Nasdaq. Trailing 12 months PER is -2.2×. Its overall grade ranks 361 of 738 stocks in Healthcare.
About this company
Regenxbio last closed at $8.07 (-0.25%) on 2026-10-09. Signals today: Golden cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B · 361/738
Valuation grade C
Related stocks
- NovartisCustomer
유전자치료제 파트너십 및 상업화 관련 핵심 고객/협력사
- Neurocrine BiosciencesCustomer
RGX-121 등 AAV 기반 유전자치료 공동개발/라이선스 파트너
- AbbVieCustomer
Regenxbio의 AAV 플랫폼을 활용한 협업 파트너
About Regenxbio
- What technical signals does Regenxbio (RGNX) have?
- Regenxbio current technical signals: golden cross (5_20, 0d ago).
- Is Regenxbio a cup-and-handle pattern?
- No. Regenxbio has no valid Cup signal right now.
- What published figures are available for Regenxbio?
- Market cap: $408.53M. Trailing 12 months PER: -2.2×. Latest quarter PBR: 5.98×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Regenxbio, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.